A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Completed · Not applicable
Conditions studied: Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non-Small Cell Lung Cancer, Thyroid Cancer, Advanced/Metastatic Non-Small Cell Lung Cancer, Advanced Gastric Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Pancreatic Islet Cell Carcinoma, Pancreatic Neuroendocrine Tumor
In brief
This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib. The patient must have been enrolled in one of the following studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future.
Key facts
- Study ID
- NCT00428220
- Run by
- Pfizer
- People needed
- 223
- Starts
- 2007-07-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2019-06-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must have ended treatment from one of the following sunitinib studies: A6181030, A6181064, A6181078, A6181087, A6181094, A6181107, A6181108, A6181110, A6181111, A6181112, A6181113, A6181120, A6181126 and A6181170. Other Pfizer sponsored sunitinib studies may be included in the future.
You may not qualify if…
- See inclusion criteria
Where it is running
- Investigational Drug Service — Atlanta, Georgia, United States
- The Emory Clinic — Atlanta, Georgia, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Siteman Cancer Center — City of Saint Peters, Missouri, United States
- Siteman Cancer Center-West County — Creve Coeur, Missouri, United States
- Barnes Jewish Hospital — St Louis, Missouri, United States
- Washington University School of Medicine, Siteman Cancer Center — St Louis, Missouri, United States
- Comprehensive Cancer Center of Nevada — Las Vegas, Nevada, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Northwest Cancer Specialists, P.C. — Portland, Oregon, United States
- Northwest Cancer Specialists, P.C. — Portland, Oregon, United States
- US Oncology Research and Clinical Pharmacy (Drug Shipment Only) — Fort Worth, Texas, United States
- The Strelitz Diabetes Institute of Eastern Virginia Medical School — Norfolk, Virginia, United States
- Instituto Oncologico de Cordoba — Nueva Cordoba, Nueva Cordoba, Argentina
- Clinica Viedma — Viedma, Río Negro Province, Argentina
- Centro Oncológico Rosario — Rosario, Santa Fe Province, Argentina
- Centro Medico San Roque — San Miguel de Tucumán, Argentina
- Royal Brisbane & Women's Hospital — Herston, Queensland, Australia
- Royal Adelaide Hospital, Department of Medical Oncology — Adelaide, South Australia, Australia
- Austin Health — Heidelberg, Victoria, Australia
- Royal Melbourne Hospital — Parkville, Victoria, Australia
- Mount Medical Centre — Perth, Western Australia, Australia
- Hopital Erasme / Gastroenterologie — Brussels, Belgium
- Emory University, Winship Cancer Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.